Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muzaffar H Qazilbash

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Current Hematologic Malignancy Reports|March 13, 2017
Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It WorkQaiser Bashir, Muzaffar H Qazilbash
European Journal of Haematology|September 5, 2020
POEMS syndrome: A multisystem clonal disorderTayyaba Ali, Muzaffar H Qazilbash
World Journal of Transplantation|November 7, 2017
Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?Whitney D Wallis, Muzaffar H Qazilbash
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
Personalized Medicine's Coming of Age: One Drug, One PatientMuzaffar H Qazilbash, Larry W Kwak
Annals of Translational Medicine|May 13, 2020
Impact of renal impairment on light chain amyloidosis outcomes after autologous hematopoietic stem cell transplantationSamer A Srour, Muzaffar H Qazilbash
Current Anesthesiology Reports|April 15, 2020
New Cancer Therapies: Implications for the Perioperative PeriodTayab Andrabi, Katy E French, Muzaffar H Qazilbash
Oncotarget|February 14, 2018
Targeting PR1 in myeloid leukemiaGheath Alatrash, Jeffrey J Molldrem, Muzaffar H Qazilbash
Hematology/Oncology Clinics of North America|July 24, 2004
Nonmyeloablative stem cell transplantation for chronic myeloid leukemiaMuzaffar H Qazilbash, Sergio A Giralt, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2017
Adverse Prognostic Factors for Morbidity and Mortality During Peripheral Blood Stem Cell Mobilization in Patients with Light Chain AmyloidosisJason C Yeh, Brandon R Shank, Denái R Milton, et al.
American Journal of Hematology|November 15, 2011
Retrospective analysis of weekly intravenous immunoglobulin prophylaxis versus intravenous immunoglobulin by IgG level monitoring in hematopoietic stem cell transplant recipientsJoshua E Howell, Alison M Gulbis, Richard E Champlin, et al.
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Current Hematologic Malignancy Reports|March 13, 2017
Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It WorkQaiser Bashir, Muzaffar H Qazilbash
European Journal of Haematology|September 5, 2020
POEMS syndrome: A multisystem clonal disorderTayyaba Ali, Muzaffar H Qazilbash
World Journal of Transplantation|November 7, 2017
Peripheral blood stem cell mobilization in multiple myeloma: Growth factors or chemotherapy?Whitney D Wallis, Muzaffar H Qazilbash
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2023
Personalized Medicine's Coming of Age: One Drug, One PatientMuzaffar H Qazilbash, Larry W Kwak
Annals of Translational Medicine|May 13, 2020
Impact of renal impairment on light chain amyloidosis outcomes after autologous hematopoietic stem cell transplantationSamer A Srour, Muzaffar H Qazilbash
Current Anesthesiology Reports|April 15, 2020
New Cancer Therapies: Implications for the Perioperative PeriodTayab Andrabi, Katy E French, Muzaffar H Qazilbash
Oncotarget|February 14, 2018
Targeting PR1 in myeloid leukemiaGheath Alatrash, Jeffrey J Molldrem, Muzaffar H Qazilbash
Hematology/Oncology Clinics of North America|July 24, 2004
Nonmyeloablative stem cell transplantation for chronic myeloid leukemiaMuzaffar H Qazilbash, Sergio A Giralt, Richard E Champlin
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 11, 2017
Adverse Prognostic Factors for Morbidity and Mortality During Peripheral Blood Stem Cell Mobilization in Patients with Light Chain AmyloidosisJason C Yeh, Brandon R Shank, Denái R Milton, et al.
American Journal of Hematology|November 15, 2011
Retrospective analysis of weekly intravenous immunoglobulin prophylaxis versus intravenous immunoglobulin by IgG level monitoring in hematopoietic stem cell transplant recipientsJoshua E Howell, Alison M Gulbis, Richard E Champlin, et al.
Pageof 19